Oxford Immunotec Reports Third Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff pulls Wall Street to two-week lows as oil and yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- U.S. EV market shows signs of bottoming out: Bernstein
Oxford Immunotec (OXFD) Tops Q3 EPS by 15c, Raises Revenue Outlook
November 1, 2016 7:12 AM EDTOxford Immunotec (NASDAQ: OXFD) reported Q3 EPS of ($0.18), $0.15 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $26.1 million versus the consensus estimate of $24.79 million.
GUIDANCE:
Oxford Immunotec sees FY2016 revenue of $85-85.8 million, versus prior... More
